Creative Medical Technology Holdings, Inc. (CELZ)
NASDAQ: CELZ · Real-Time Price · USD
0.9464
+0.0047 (0.50%)
At close: Oct 2, 2026, 4:00 PM EDT
0.9400
-0.0064 (-0.68%)
After-hours: Oct 2, 2026, 6:41 PM EDT
CELZ Market Cap
CELZ has a market cap or net worth of $6.24 million as of October 2, 2026. Its market cap has decreased by -27.45% in one year.
Market Cap
6.24M
Enterprise Value
-2.59M
1-Year Change
-27.45%
Ranking
Category
Stock Price
$0.95
ChartMarket Cap Chart
Since December 3, 2021, CELZ's market cap has decreased from $16.10M to $6.24M, a decrease of -61.25%. That is a compound annual growth rate of -17.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 6.20M | 21.57% |
| Dec 31, 2025 | 5.10M | 27.50% |
| Dec 31, 2024 | 4.00M | -37.50% |
| Dec 29, 2023 | 6.40M | 18.52% |
| Dec 30, 2022 | 5.40M | -66.46% |
| Dec 31, 2021 | 16.10M | - |
| Dec 3, 2021 | 16.10M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Acurx Pharmaceuticals | 6.69M |
| Bolt Biotherapeutics | 6.65M |
| Enveric Biosciences | 6.62M |
| Alzamend Neuro | 6.61M |
| CollPlant Biotechnologies | 6.54M |
| Can-Fite BioPharma | 6.50M |
| Evogene | 6.32M |
| Lunai Bioworks | 5.89M |